Royalty Pharma Investments 2019 ICAV - Director, 10%+ Owner at Epizyme, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director, 10%+ Owner
Issuer Symbol: EPZM
All Insider Reports: All Insider Reports

There are no Buy or Sell transactions made by Royalty Pharma Investments 2019 ICAV since 11 Mar 2025

Holdings reported by Royalty Pharma Investments 2019 ICAV for Epizyme, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	22,666,667	$31,960,000	$1.41	31 Jan 2022	Direct

There are no transactions reported by Royalty Pharma Investments 2019 ICAV for Epizyme, Inc.